BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 18, 2026
Home » Topics » Science

Science
Science RSS Feed RSS

Glucose testing

New therapeutic target for blood sugar control identified

Sep. 2, 2020
By John Fox
An Australian study led by University of Melbourne scientists has identified a previously unknown role for the hepatokine, sparc-related modular calcium-binding protein 1 (SMOC1), in suppressing hepatic glucose production. The investigators reported their results in the Sept. 2, 2020, edition of Science Translational Medicine.
Read More

BioWorld MedTech’s Orthopedics Extra for Sept. 2, 2020

Sep. 2, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Implant choice more important than surgeon skill for hip replacement success; Vertebral body tethering shows clinical success as treatment for scoliosis; Hip fracture risk linked to nanoscale bone inflexibility; Bioventus reports first use of its Signfuse bioactive bone graft in strip format.
Read More

BioWorld MedTech’s Oncology Extra for Sept. 1, 2020

Sep. 1, 2020
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: Denoising algorithm may boost signal-to-noise ratios in prostate MRI; Cross-reactive immunity helps antitumor response; iBET you I can kill those metastases; Transatlantic assault on cancer announced.
Read More

BioWorld MedTech’s Cardiology Extra for Aug. 31, 2020

Aug. 31, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology, including: 3D printing of heart valve models; Findings challenge recommendations for antiplatelet treatment after TAVI; Telehealth could help those with high BP avoid heart attack, stroke.
Read More
Galanin in the brainstem
Bench Press

How running away from your problems works

Aug. 31, 2020
By Anette Breindl
BioWorld looks at translational medicine: Researchers at Emory University have gained new insights into how exercise confers stress resilience.
Read More
Vaccination
Vaccine durability

Thanks for the memories, but could you make them less selective?

Aug. 28, 2020
By Anette Breindl
With COVID-19, questions about how infections cause lasting immunity, or don’t, and how you know and what it all means for vaccines have become a matter of public focus. But some immunologists have been pondering those questions for years. “The immune system has a very good memory,” Bali Pulendran told BioWorld. “Clearly, some viruses and some pathogens can enter the body and stimulate the immune system, and the immune system can remember that encounter for decades.”
Read More

BioWorld MedTech’s Neurology Extra for Aug. 28, 2020

Aug. 28, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Blood-based test used to predict who is likely to develop psychotic disorders; Study could lead to more personalized choices for OCD treatment; Nerve cells differ before birth in people with ASD.
Read More
Cancer cell

Bench Press for Aug. 28, 2020

Aug. 28, 2020
BioWorld looks at translational medicine, including: iBET you I can kill those metastases; Elite controller achieves none-in-a-billion status; AP-1 and antidepressant action; ‘Undruggable’ phosphatase can be targeted for dystrophies; Candida auris: mostly, nothing wrong; In T cells, exhaustion starts young; Chewing the fat keeps stem cells quiet; Antiviral protein produces flu mRNAs; Engineered brown fat cells improve blood sugar control; For organs, rejuvenation helps transplantation.
Read More

BioWorld MedTech’s Diagnostics Extra for Aug. 27, 2020

Aug. 27, 2020
By Meg Bryant and Anette Breindl
Keeping you up to date on recent developments in diagnostics, including: A.I. tool promises faster, more accurate Alzheimer's diagnosis; Bioluminescent tool tracks DNA break repair; Mechanisms of retinopathy come into focus.
Read More

BioWorld MedTech’s Orthopedics Extra for Aug. 26, 2020

Aug. 26, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Hip fracture risk linked to nanoscale bone inflexibility; High intensity physical activity in early life could lead to stronger bones in adulthood; Xtant Medical reports U.S. launch of the Matriform Si; Opioid prescription rates for knee surgery vary, but higher strength dosage common.
Read More
Previous 1 2 … 148 149 150 151 152 153 154 155 156 … 201 202 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 17, 2026.
  • Senior medical exam

    Celia trial: data strong, analysts skeptical

    BioWorld
    Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • Illustration of human brain and dna

    Voyager’s gene therapy reduces tau levels in AD models

    BioWorld Science
    At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
  • Illustration of T cells attacking cancer

    GABA signaling linked to immune resistance in some tumors

    BioWorld
    Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing